Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 64 of 97, showing 5 Applications out of 482 total, starting on record 316, ending on 320

# Protocol No Study Title Investigator(s) & Site(s)

316.

ECCT/21/11/02   SONIA Trial
    A Pragmatic Randomized Controlled Trial of Standard Care versus Steroids plus Standard Care for Treatment of Pneumonia in Adults Admitted to Kenyan Hospitals       
Principal Investigator(s)
1. Anthony Oliwa Etyang
2. Samuel Owuor Akech
Site(s) in Kenya
1. Kilifi County Hospital (Kilifi county)
2. Mbagathi Sub-county Hospital (Nairobi City county)
3. Busia County Referral Hospital (Busia county)
4. Bungoma County Referral Hospital (Bung\'oma county)
5. Kisumu County Hospital (Kisumu county)
6. Machakos Level 5 Hospital (Machakos county)
7. Mama Lucy Kibaki Hospital (Nairobi City county)
8. Kitale County Referral Hospital (Trans Nzoia county)
9. Kiambu County Hospital (Kiambu county)
10. Kakamega County Hospital (Kakamega county)
 
View

317.

ECCT/19/06/01   EPI 003
    A prospective study to evaluate the safety, effectiveness and impact of the RTS,S/AS01E vaccine in young children in sub-Saharan Africa.   
Principal Investigator(s)
1. Walter Otieno
Site(s) in Kenya
1. Ahero clinical triasl unit (Kisumu county)
2. KEMI CDC (Siaya county)
 
View

318.

ECCT/18/11/02   EPI 003
    A prospective study to evaluate the safety, effectiveness and impact of the RTS,S/AS01E vaccine in young children in sub-Saharan Africa.   
Principal Investigator(s)
1. BERNHARDS OGUTU
Site(s) in Kenya
1. • Ahero Clinical Trials Unit (Kisumu county)
2. KEMRI Walter Reed Army Institute of Research (Kisumu county)
3. KEMRI CDC SIAYA (Siaya county)
 
View

319.

ECCT/09/03/01   REMoxTB
    A randomised placebo – controlled double blind trial comparing two treatment shortening regimens with the standard regimen (two months ethambutol,  isoniazid, rifampicin and pyrazinamide followed by four months isoniazid and rifampicin) namely 1) two months moxifloxacin, isoniazid, rifampicin and  pyrazinamide followed by two months moxifloxacin, isoniazid and rifampicin and 2) two months ethambutol, moxifloxacin, rifampicin and pyrazinamide followed by  two months moxifloxacin and rifampicin for the treatment of adults with pulmonary tuberculosis   
Principal Investigator(s)
1. Evans Inyangala Amukoye
Site(s) in Kenya
Kibera D.O Health Centre
 
View

320.

ECCT/18/07/06   Hestia 3
    A Randomised, Double-Blind, Parallel-Group, Multicentre, Phase III Study to Evaluate the Effect of Ticagrelor versus Placebo in Reducing the Rate of Vaso-Occlusive Crises in Paediatric Patients with Sickle Cell Disease   
Principal Investigator(s)
1. Prof Jessie Nyokabi Githanga
2. Videlis Nduba
3. Janet N Oyieko
4. Bernards Ragama Ogutu
Site(s) in Kenya
1. Gertrude’s Children’s Hospital (Nairobi City county)
2. Chandaria Health Center Clinical Research Clinic (Nairobi City county)
3. Kenya Medical Research Institute (KEMRI) Kisumu (Kisumu county)
4. KEMRI Kombewa Clinical Research Centre (Nairobi City county)
5. Kondele Children\'s Hospital (Kisumu county)
6. Strathmore University Medical Centre (Nairobi City county)
 
View